Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Injection
other · Food and Drug Administration · Rule · Published 1999-05-17 · Effective 1999-05-17 · 64 FR 26670
Document
Document number
99-12284
Federal Register citation
64 FR 26670
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1999-05-17
Effective date
1999-05-17
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Boehringer Ingelheim Vetmedica, Inc. The supplemental ANADA provides for establishment of a 28-day withdrawal period for subcutaneous use of oxytetracycline injection in cattle and for intramuscular use in swine.